Insider · CIK 0001465144

Domain Partners VIII, L.P.

Reports to the SEC for 12 companies · PRINCETON, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001465144

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2018-08-23	BNGOBionano Genomics, Inc.C Conversion	10% Owner	CConversion	+338K sh	$4.59	+$1.55M	929,878
2018-08-23	BNGOBionano Genomics, Inc.P Purchase	10% Owner	PPurchase	+15K sh	$6.13	+$91.9K	943,878
2018-08-23	BNGOBionano Genomics, Inc. · Series B Preferred StockC Conversion	10% Owner	CConversion	−6.81M sh	—	—	0
2018-08-23	BNGOBionano Genomics, Inc. · Series B-1 Preferred StockC Conversion	10% Owner	CConversion	−2.99M sh	—	—	0
2018-08-23	BNGOBionano Genomics, Inc. · Series C Preferred StockC Conversion	10% Owner	CConversion	−5.43M sh	—	—	0
2018-08-23	BNGOBionano Genomics, Inc. · Series D Preferred StockC Conversion	10% Owner	CConversion	−6.4M sh	—	—	0
2018-08-23	BNGOBionano Genomics, Inc. · Series D-1 Preferred StockC Conversion	10% Owner	CConversion	−3.68M sh	—	—	0
2018-08-23	BNGOBionano Genomics, Inc. · Convertible Promissory NoteC Conversion	10% Owner	CConversion	—	—	—	0
2018-08-23	BNGOBionano Genomics, Inc. · Warrants to Purchase Common StockP Purchase	10% Owner	PPurchase	+15K sh	—	—	15,000
2018-08-23	BNGOBionano Genomics, Inc.C Conversion	10% Owner	CConversion	+591K sh	—	—	591,184
2017-12-18	Dicerna Pharmaceuticals IncC Conversion	10% Owner	CConversion	+1.68M sh	$3.19	+$5.35M	3,431,139
2017-12-18	Dicerna Pharmaceuticals IncA Award	10% Owner	AAward	+37.9K sh	—	—	3,469,029
2017-12-18	Dicerna Pharmaceuticals IncRedeemable Convertible Preferred StockC Conversion	10% Owner	CConversion	−49.6K sh	—	—	0
2017-12-11	Ocera Therapeutics, Inc.D Disposition to Issuer	10% Owner	DDisposition to Issuer	−988K sh	—	—	0
2017-04-11	Dicerna Pharmaceuticals IncRedeemable Convertible Preferred StockP Purchase	10% Owner	PPurchase	+49.6K sh	$100.00	+$4.96M	49,632
2016-03-08	SNDXSyndax Pharmaceuticals IncC Conversion	10% Owner	CConversion	+761K sh	—	—	761,062
2016-03-08	SNDXSyndax Pharmaceuticals Inc · Series B-1 Preferred StockC Conversion	10% Owner	CConversion	−400K sh	—	—	0
2016-03-08	SNDXSyndax Pharmaceuticals Inc · Series C-1 Preferred StockC Conversion	10% Owner	CConversion	−361K sh	—	—	0
2015-06-30	GKOSGLAUKOS CorpC Conversion	10% Owner	CConversion	+876K sh	—	—	876,083
2015-06-30	GKOSGLAUKOS Corp · Series E Preferred StockC Conversion	10% Owner	CConversion	−589K sh	—	—	0
2015-06-30	GKOSGLAUKOS Corp · Series F Preferred StockC Conversion	10% Owner	CConversion	−287K sh	—	—	0
2015-05-12	ATYRaTYR PHARMA INC · Series E Preferred StockC Conversion	10% Owner	CConversion	−887K sh	—	—	0
2015-05-12	ATYRaTYR PHARMA INCC Conversion	10% Owner	CConversion	+1.81M sh	—	—	1,807,820
2015-05-12	ATYRaTYR PHARMA INC · Series C Preferred StockC Conversion	10% Owner	CConversion	−12.1M sh	—	—	0
2015-05-12	ATYRaTYR PHARMA INC · Series D Preferred StockC Conversion	10% Owner	CConversion	−1.51M sh	—	—	0
2014-11-17	Durata Therapeutics, Inc.D Disposition to Issuer	10% Owner	DDisposition to Issuer	−3.01M sh	—	—	0
2014-10-21	ATRAAtara Biotherapeutics, Inc.C Conversion	10% Owner	CConversion	+1.89M sh	—	—	1,893,383
2014-10-21	ATRAAtara Biotherapeutics, Inc.P Purchase	10% Owner	PPurchase	+248K sh	$11.00	+$2.73M	2,141,542
2014-10-21	ATRAAtara Biotherapeutics, Inc. · Series A Preferred StockC Conversion	10% Owner	CConversion	−1.27M sh	—	—	0
2014-10-21	ATRAAtara Biotherapeutics, Inc. · Series B Preferred StockC Conversion	10% Owner	CConversion	−621K sh	—	—	0
2014-09-10	VCYTVERACYTE, INC.J Other	10% Owner	JOther	−300K sh	—	—	2,763,294
2014-08-18	OTONOMY, INC.F Tax Payment	10% Owner	FTax Payment	−37.2K sh	$16.00	−$596K	1,579,323
2014-08-18	OTONOMY, INC.M Exercise/Conversion	10% Owner	MExercise/Conversion	+67.8K sh	$8.79	+$596K	1,616,547
2014-08-18	OTONOMY, INC.C Conversion	10% Owner	CConversion	+1.55M sh	—	—	1,548,792
2014-08-18	OTONOMY, INC.Series C Preferred Stock Warrant (Right to Buy)M Exercise/Conversion	10% Owner	MExercise/Conversion	−67.8K sh	—	—	0
2014-08-18	OTONOMY, INC.Series D Preferred StockF Tax Payment	10% Owner	FTax Payment	−187K sh	—	—	0
2014-08-18	OTONOMY, INC.Series B Preferred StockC Conversion	10% Owner	CConversion	−436K sh	—	—	0
2014-08-18	OTONOMY, INC.Series C Preferred StockC Conversion	10% Owner	CConversion	−925K sh	—	—	0
2014-02-04	Dicerna Pharmaceuticals IncSeries B Preferred StockC Conversion	10% Owner	CConversion	−476K sh	—	—	0
2014-02-04	Dicerna Pharmaceuticals IncSeries C Preferred StockC Conversion	10% Owner	CConversion	−1.28M sh	—	—	0
2014-02-04	Dicerna Pharmaceuticals IncWarrantC Conversion	10% Owner	CConversion	−21K sh	—	—	0
2014-02-04	Dicerna Pharmaceuticals IncWarrantC Conversion	10% Owner	CConversion	+21K sh	—	—	21,041
2014-02-04	Dicerna Pharmaceuticals IncC Conversion	10% Owner	CConversion	+1.75M sh	—	—	1,752,707
2013-11-04	VCYTVERACYTE, INC. · Series B Preferred StockC Conversion	10% Owner	CConversion	−2.38M sh	—	—	0
2013-11-04	VCYTVERACYTE, INC.C Conversion	10% Owner	CConversion	+3.06M sh	—	—	3,063,294
2013-11-04	VCYTVERACYTE, INC. · Series C Preferred StockC Conversion	10% Owner	CConversion	−681K sh	—	—	0
2013-01-18	ACHILLION PHARMACEUTICALS INCJ Other	10% Owner	JOther	−1M sh	—	—	5,772,968
2012-07-24	Durata Therapeutics, Inc.Series A Preferred StockC Conversion	10% Owner	CConversion	−2.23M sh	—	—	0
2012-07-24	Durata Therapeutics, Inc.P Purchase	10% Owner	PPurchase	+779K sh	$9.00	+$7.01M	3,006,132
2012-07-24	Durata Therapeutics, Inc.C Conversion	10% Owner	CConversion	+2.23M sh	—	—	2,227,596

Recent filings

Accepted (ET)
Aug 274
Domain Partners VIII, L.P.0000904454-18-000522
SEC(opens sec.gov)
Dec 204
Halak Brian K0000904454-17-000739
SEC(opens sec.gov)
Dec 134
Halak Brian K0000904454-17-000718
SEC(opens sec.gov)
Apr 124
Dicerna Pharmaceuticals Inc0000904454-17-000304
SEC(opens sec.gov)
Mar 84
Syndax Pharmaceuticals Inc0000904454-16-001105
SEC(opens sec.gov)
Jul 14
GLAUKOS Corp0000904454-15-000443
SEC(opens sec.gov)

Companies

Address

C/O DOMAIN ASSOCIATES, L.L.C. ONE PALMER SQUARE

PRINCETON, NJ, 08542